Active, Not Recruiting
Randomized Autologous heMatopoietic Stem Cell Transplantation Versus Alemtuzumab, Cladribine or Ocrelizumab for RRMS (RAM-MS)
NCT03477500
- Conditions
- Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Demyelinating Autoimmune Diseases, CNS, +4 more
- Locations
-
- Rigshospitalet Copenhagen, Denmark
- VUmc Amsterdam, Netherlands
- Haukeland University Hospital Bergen, Norway
- Akershus University Hospital Oslo, Norway